HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Collantes Selected Research

Etoricoxib

5/2002A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Collantes Research Topics

Disease

9Ankylosing Spondylitis
11/2020 - 09/2007
5Rheumatoid Arthritis
01/2021 - 05/2002
3Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022 - 10/2011
2Arthritis (Polyarthritis)
10/2018 - 05/2002
2Uveitis
10/2018 - 09/2011
2Joint Diseases (Joint Disease)
03/2010 - 01/2009
1Atherosclerosis
01/2019
1Disease Progression
01/2019
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Thrombosis (Thrombus)
01/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2018
1Back Pain (Backache)
11/2013
1Axial Spondyloarthritis
11/2013
1Sacroiliitis
11/2013
1Spondylarthritis (Spinal Arthritis)
10/2011
1Familial Mediterranean Fever (Periodic Disease)
07/2008
1Inflammation (Inflammations)
07/2008
1Localized Scleroderma (Morphea)
12/2006
1Ulcer
12/2006
1Hyperuricemia
05/2005
1Hypertriglyceridemia
05/2005
1Osteoarthritis
06/2004
1Knee Osteoarthritis
06/2004
1Psoriatic Arthritis
08/2002
1Gynecomastia
08/2002
1Erectile Dysfunction
08/2002

Drug/Important Bio-Agent (IBA)

8HLA-B27 Antigen (HLA B27 Antigen)IBA
12/2022 - 04/2010
3Biomarkers (Surrogate Marker)IBA
01/2019 - 07/2008
2Tumor Necrosis Factor InhibitorsIBA
01/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2008
2C-Reactive ProteinIBA
10/2018 - 06/2011
2AntigensIBA
05/2012 - 07/2008
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2011 - 05/2002
1InflammasomesIBA
01/2020
1Thromboplastin (Tissue Factor)IBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1AntibodiesIBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Cardiolipins (Cardiolipin)IBA
01/2019
1Antiphospholipid AntibodiesIBA
01/2019
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2019
1Type II Tumor Necrosis Factor ReceptorsIBA
07/2015
1HLA-DPA1 antigen (HLA DPA1)IBA
11/2011
1HLA-DPB1 antigen (HLA DPB1)IBA
11/2011
1Etanercept (Enbrel)FDA Link
10/2011
1Indicators and Reagents (Reagents)IBA
03/2010
1amsonic acid (DAS)IBA
03/2010
1Infliximab (Remicade)FDA Link
01/2009
1Peroxidase (Myeloperoxidase)IBA
01/2009
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
07/2008
1ColchicineFDA LinkGeneric
07/2008
1AA amyloidosisIBA
07/2008
1AutoantibodiesIBA
07/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007
1Bosentan (Tracleer)FDA Link
12/2006
1Endothelin Receptor AntagonistsIBA
12/2006
1Uric Acid (Urate)IBA
05/2005
1Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2005
1Apolipoprotein C-IIIIBA
05/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2004
1GlucocorticoidsIBA
06/2004
1Antirheumatic Agents (DMARD)IBA
08/2002
1Methotrexate (Mexate)FDA LinkGeneric
08/2002
1EtoricoxibIBA
05/2002
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2002

Therapy/Procedure

3Therapeutics
06/2011 - 12/2006
1Hip Prosthesis
09/2011